Enter your login e-mail to the account
Search
Search parameters
Search results
- Is age the limitation of metastatic treatment prostate cancer?
MUDr. Jana Katolická, Ph.D.
(5/2018, Review articles ) - PARP inhibitors in treating metastatic castration-resistant prostate cancer
MUDr. Igor Richter, Ph.D., doc. MUDr. Josef Dvořák, Ph.D., MUDr. Vladimír Šámal, Ph.D., MUDr. Jiří Bartoš, MBA, MUDr. Sofya Al-Samsam
(3/2023, Review articles ) - The role of ARTAs in treating metastatic castration-resistant prostate cancer
MUDr. PharmDr. Jan Dvořák
(2/2019, Review articles ) - Have we found an optimal sequence in the treatment of metastatic castrationally-resistant prostate cancer?
MUDr. Tomaš Svoboda, Ph.D.
(1/2019, Review articles )
- Lutetium-177-PSMA in therapy of metastatic prostate cancer
MUDr. Eva Takácsová, PhD.
(4/2022, Main topic ) - Current possibilities and view of treatment of castration refractory metastatic prostate cancer
MUDr. Radovan Barilla, PhD.
(5/2019, Main topic ) - Treatment of patient with metastatic castrate refractory prostate cancer after androgen deprivation therapy failure
MUDr. Jozef Babeľa, PhD.
(S1/2019, Case reports ) - Favourable therapeutic response of enzalutamide in patient with metastatic castration resistant prostate cancer
MUDr. Martin Romančík, PhD., MPH
(S1/2019, Case reports ) - Správa z XXI. košických chemoterapeutických dní
MUDr. Jana Jankurová
(1/2018, Events ) - Glukokortikoidy v liečbe kastračne-rezistentného karcinómu prostaty a mechanizmy rezistencie na androgénnu blokádu
JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2018, Review articles )